Astrazen
Live Price
Recent news and updates for ASTRAZEN will appear here soon.
"Caution advised for ASTRAZEN investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company has a strategic collaboration with Leica Biosystems and Daiichi Sankyo Company, Limited for the development of an immunohistochemistry assay and an image analysis algorithm for the TROP2 NMR biomarker in non-small cell lung cancer. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
As of the latest market session, Astrazen (ASTRAZEN) is trading at ₹8,005.5, representing a move of 1.70% from the previous close.
Astrazen is listed and traded under the ticker symbol ASTRAZEN on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Astrazen's stock price moved by 1.70%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 18% bullish probability for ASTRAZEN stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Astrazen shares reached a high of ₹9,849.5 and hit a low of ₹7,551.5.
ASTRAZEN exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 14,182 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Astrazen has a market capitalization of ₹20013.75 Cr, designating its size class inside the Healthcare sector.
Astrazen has a current dividend yield of 45.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Astrazen's trailing Price-to-Earnings (P/E) ratio is 106.39. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Astrazen (ASTRAZEN) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Astrazen's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore ASTRAZEN's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for ASTRAZEN are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Astrazen operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.